From the Wires
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Anthera Pharmaceuticals, Inc. in Connection with Executive Compensation
By: PR Newswire
Jan. 23, 2013 02:55 PM
NEW YORK, Jan. 23, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Anthera Pharmaceuticals, Inc. (NasdaqGM: ANTH), and its Board of Directors, in connection with the compensation provided to certain of its executive officers.
To get more information, click here: http://zlk.9nl.com/anthera-pharmaceuticals-anth/. There is no cost or obligation to you.
If you own common stock in Anthera Pharmaceuticals, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/anthera-pharmaceuticals-anth/.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE Levi & Korsinsky, LLP
SOA World Latest Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week